nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—ADRB1—stomach cancer	0.485	0.543	CbGaD
Carteolol—ADRB2—stomach cancer	0.408	0.457	CbGaD
Carteolol—Lacrimation—Floxuridine—stomach cancer	0.00585	0.0613	CcSEcCtD
Carteolol—Lacrimation increased—Floxuridine—stomach cancer	0.00373	0.0391	CcSEcCtD
Carteolol—Photophobia—Floxuridine—stomach cancer	0.00323	0.0339	CcSEcCtD
Carteolol—Cardiac failure congestive—Mitomycin—stomach cancer	0.00216	0.0226	CcSEcCtD
Carteolol—Lacrimation—Irinotecan—stomach cancer	0.00199	0.0209	CcSEcCtD
Carteolol—Lacrimation—Fluorouracil—stomach cancer	0.00191	0.02	CcSEcCtD
Carteolol—Rash generalised—Docetaxel—stomach cancer	0.00191	0.02	CcSEcCtD
Carteolol—Diabetic—Methotrexate—stomach cancer	0.00175	0.0183	CcSEcCtD
Carteolol—Lacrimation—Docetaxel—stomach cancer	0.00138	0.0144	CcSEcCtD
Carteolol—Eye irritation—Fluorouracil—stomach cancer	0.00131	0.0138	CcSEcCtD
Carteolol—Lacrimation increased—Irinotecan—stomach cancer	0.00127	0.0133	CcSEcCtD
Carteolol—Lacrimation increased—Fluorouracil—stomach cancer	0.00122	0.0128	CcSEcCtD
Carteolol—Keratitis—Capecitabine—stomach cancer	0.00121	0.0127	CcSEcCtD
Carteolol—Vision blurred—Mitomycin—stomach cancer	0.00111	0.0117	CcSEcCtD
Carteolol—Syncope—Mitomycin—stomach cancer	0.00106	0.0111	CcSEcCtD
Carteolol—Photophobia—Fluorouracil—stomach cancer	0.00105	0.011	CcSEcCtD
Carteolol—Loss of consciousness—Mitomycin—stomach cancer	0.00104	0.0109	CcSEcCtD
Carteolol—Oedema—Mitomycin—stomach cancer	0.000962	0.0101	CcSEcCtD
Carteolol—Eye irritation—Docetaxel—stomach cancer	0.000948	0.00995	CcSEcCtD
Carteolol—Shock—Mitomycin—stomach cancer	0.000947	0.00993	CcSEcCtD
Carteolol—Lacrimation—Epirubicin—stomach cancer	0.000929	0.00974	CcSEcCtD
Carteolol—Eye irritation—Capecitabine—stomach cancer	0.000918	0.00963	CcSEcCtD
Carteolol—Hypersensitivity—Floxuridine—stomach cancer	0.000904	0.00948	CcSEcCtD
Carteolol—Visual disturbance—Irinotecan—stomach cancer	0.000897	0.00941	CcSEcCtD
Carteolol—Asthenia—Floxuridine—stomach cancer	0.00088	0.00923	CcSEcCtD
Carteolol—Lacrimation increased—Docetaxel—stomach cancer	0.000879	0.00922	CcSEcCtD
Carteolol—Cerebrovascular accident—Irinotecan—stomach cancer	0.000868	0.0091	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—stomach cancer	0.00086	0.00902	CcSEcCtD
Carteolol—Dyspnoea—Mitomycin—stomach cancer	0.000858	0.009	CcSEcCtD
Carteolol—Lacrimation increased—Capecitabine—stomach cancer	0.000851	0.00892	CcSEcCtD
Carteolol—Keratitis—Epirubicin—stomach cancer	0.000842	0.00883	CcSEcCtD
Carteolol—Respiratory failure—Docetaxel—stomach cancer	0.000825	0.00865	CcSEcCtD
Carteolol—Levobunolol—ADRB1—stomach cancer	0.000804	0.0866	CrCbGaD
Carteolol—Keratitis—Doxorubicin—stomach cancer	0.000779	0.00817	CcSEcCtD
Carteolol—Headache—Floxuridine—stomach cancer	0.000768	0.00806	CcSEcCtD
Carteolol—Nausea—Floxuridine—stomach cancer	0.000729	0.00764	CcSEcCtD
Carteolol—Asthenia—Mitomycin—stomach cancer	0.000691	0.00724	CcSEcCtD
Carteolol—Levobunolol—ADRB2—stomach cancer	0.000676	0.0729	CrCbGaD
Carteolol—Diabetes mellitus—Capecitabine—stomach cancer	0.000654	0.00686	CcSEcCtD
Carteolol—Cardiac failure congestive—Docetaxel—stomach cancer	0.000648	0.0068	CcSEcCtD
Carteolol—Dizziness—Mitomycin—stomach cancer	0.000636	0.00668	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—stomach cancer	0.00062	0.00651	CcSEcCtD
Carteolol—Conjunctivitis—Fluorouracil—stomach cancer	0.00061	0.0064	CcSEcCtD
Carteolol—Nadolol—ADRB1—stomach cancer	0.00061	0.0657	CrCbGaD
Carteolol—Headache—Mitomycin—stomach cancer	0.000603	0.00632	CcSEcCtD
Carteolol—Bradycardia—Irinotecan—stomach cancer	0.000599	0.00628	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—stomach cancer	0.000594	0.00623	CcSEcCtD
Carteolol—Lacrimation increased—Epirubicin—stomach cancer	0.000593	0.00622	CcSEcCtD
Carteolol—Sinusitis—Fluorouracil—stomach cancer	0.000589	0.00618	CcSEcCtD
Carteolol—Bupranolol—ADRB1—stomach cancer	0.000582	0.0626	CrCbGaD
Carteolol—Cerebrovascular accident—Capecitabine—stomach cancer	0.000581	0.00609	CcSEcCtD
Carteolol—Nausea—Mitomycin—stomach cancer	0.000572	0.006	CcSEcCtD
Carteolol—Diplopia—Capecitabine—stomach cancer	0.000569	0.00597	CcSEcCtD
Carteolol—Visual impairment—Irinotecan—stomach cancer	0.000567	0.00595	CcSEcCtD
Carteolol—Atrioventricular block—Epirubicin—stomach cancer	0.000563	0.00591	CcSEcCtD
Carteolol—Bopindolol—ADRB1—stomach cancer	0.000558	0.0601	CrCbGaD
Carteolol—Lacrimation increased—Doxorubicin—stomach cancer	0.000548	0.00575	CcSEcCtD
Carteolol—Salbutamol—ADRB1—stomach cancer	0.000547	0.0589	CrCbGaD
Carteolol—Penbutolol—ADRB1—stomach cancer	0.000532	0.0573	CrCbGaD
Carteolol—Arrhythmia—Irinotecan—stomach cancer	0.000526	0.00551	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—stomach cancer	0.000521	0.00547	CcSEcCtD
Carteolol—Nadolol—ADRB2—stomach cancer	0.000513	0.0552	CrCbGaD
Carteolol—Arrhythmia—Fluorouracil—stomach cancer	0.000503	0.00528	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—stomach cancer	0.0005	0.00524	CcSEcCtD
Carteolol—Bopindolol—HTR1A—stomach cancer	0.000499	0.0537	CrCbGaD
Carteolol—Bupranolol—ADRB2—stomach cancer	0.000489	0.0527	CrCbGaD
Carteolol—Diabetes mellitus—Methotrexate—stomach cancer	0.000487	0.00511	CcSEcCtD
Carteolol—Bronchospasm—Capecitabine—stomach cancer	0.000484	0.00508	CcSEcCtD
Carteolol—Penbutolol—HTR1A—stomach cancer	0.000476	0.0513	CrCbGaD
Carteolol—Bopindolol—ADRB2—stomach cancer	0.000469	0.0505	CrCbGaD
Carteolol—Vision blurred—Fluorouracil—stomach cancer	0.000462	0.00485	CcSEcCtD
Carteolol—Salbutamol—ADRB2—stomach cancer	0.00046	0.0495	CrCbGaD
Carteolol—Syncope—Irinotecan—stomach cancer	0.000459	0.00482	CcSEcCtD
Carteolol—Diabetes mellitus—Epirubicin—stomach cancer	0.000456	0.00478	CcSEcCtD
Carteolol—Loss of consciousness—Irinotecan—stomach cancer	0.00045	0.00472	CcSEcCtD
Carteolol—Penbutolol—ADRB2—stomach cancer	0.000447	0.0482	CrCbGaD
Carteolol—Visual disturbance—Methotrexate—stomach cancer	0.000447	0.00469	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—stomach cancer	0.00044	0.00462	CcSEcCtD
Carteolol—Depression—Capecitabine—stomach cancer	0.000437	0.00459	CcSEcCtD
Carteolol—Cardiac failure congestive—Epirubicin—stomach cancer	0.000437	0.00459	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—stomach cancer	0.000432	0.00453	CcSEcCtD
Carteolol—Conjunctivitis—Capecitabine—stomach cancer	0.000426	0.00447	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—stomach cancer	0.000422	0.00442	CcSEcCtD
Carteolol—Oedema—Irinotecan—stomach cancer	0.000418	0.00438	CcSEcCtD
Carteolol—Shock—Irinotecan—stomach cancer	0.000411	0.00431	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—stomach cancer	0.000406	0.00426	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—stomach cancer	0.000405	0.00424	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000405	0.00424	CcSEcCtD
Carteolol—Bradycardia—Capecitabine—stomach cancer	0.000401	0.0042	CcSEcCtD
Carteolol—Oedema—Fluorouracil—stomach cancer	0.0004	0.0042	CcSEcCtD
Carteolol—Diplopia—Epirubicin—stomach cancer	0.000397	0.00416	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—stomach cancer	0.000392	0.00411	CcSEcCtD
Carteolol—Hypotension—Irinotecan—stomach cancer	0.000391	0.0041	CcSEcCtD
Carteolol—Pindolol—ADRB1—stomach cancer	0.000383	0.0413	CrCbGaD
Carteolol—Visual impairment—Capecitabine—stomach cancer	0.000379	0.00398	CcSEcCtD
Carteolol—Insomnia—Irinotecan—stomach cancer	0.000378	0.00397	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—stomach cancer	0.000376	0.00394	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000374	0.00393	CcSEcCtD
Carteolol—Hypotension—Fluorouracil—stomach cancer	0.000374	0.00392	CcSEcCtD
Carteolol—Dyspnoea—Irinotecan—stomach cancer	0.000373	0.00391	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—stomach cancer	0.000367	0.00385	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—stomach cancer	0.000363	0.00381	CcSEcCtD
Carteolol—Insomnia—Fluorouracil—stomach cancer	0.000362	0.0038	CcSEcCtD
Carteolol—Dyspnoea—Fluorouracil—stomach cancer	0.000357	0.00374	CcSEcCtD
Carteolol—Arrhythmia—Capecitabine—stomach cancer	0.000352	0.00369	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—stomach cancer	0.000347	0.00364	CcSEcCtD
Carteolol—Pindolol—HTR1A—stomach cancer	0.000343	0.037	CrCbGaD
Carteolol—Dysgeusia—Capecitabine—stomach cancer	0.000336	0.00352	CcSEcCtD
Carteolol—Depression—Methotrexate—stomach cancer	0.000326	0.00341	CcSEcCtD
Carteolol—Vision blurred—Capecitabine—stomach cancer	0.000323	0.00339	CcSEcCtD
Carteolol—Pindolol—ADRB2—stomach cancer	0.000322	0.0347	CrCbGaD
Carteolol—Syncope—Docetaxel—stomach cancer	0.000317	0.00333	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—stomach cancer	0.000317	0.00333	CcSEcCtD
Carteolol—Palpitations—Docetaxel—stomach cancer	0.000313	0.00328	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—stomach cancer	0.000311	0.00326	CcSEcCtD
Carteolol—Hypersensitivity—Irinotecan—stomach cancer	0.000308	0.00323	CcSEcCtD
Carteolol—Syncope—Capecitabine—stomach cancer	0.000307	0.00322	CcSEcCtD
Carteolol—Palpitations—Capecitabine—stomach cancer	0.000303	0.00318	CcSEcCtD
Carteolol—Loss of consciousness—Capecitabine—stomach cancer	0.000301	0.00316	CcSEcCtD
Carteolol—Asthenia—Irinotecan—stomach cancer	0.0003	0.00315	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—stomach cancer	0.000297	0.00312	CcSEcCtD
Carteolol—Hypersensitivity—Fluorouracil—stomach cancer	0.000295	0.00309	CcSEcCtD
Carteolol—Oedema—Docetaxel—stomach cancer	0.000289	0.00303	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—stomach cancer	0.000287	0.00301	CcSEcCtD
Carteolol—Shock—Docetaxel—stomach cancer	0.000284	0.00298	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—stomach cancer	0.000282	0.00296	CcSEcCtD
Carteolol—Oedema—Capecitabine—stomach cancer	0.00028	0.00293	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—stomach cancer	0.000279	0.00293	CcSEcCtD
Carteolol—Dizziness—Irinotecan—stomach cancer	0.000276	0.0029	CcSEcCtD
Carteolol—Shock—Capecitabine—stomach cancer	0.000275	0.00289	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—stomach cancer	0.000275	0.00288	CcSEcCtD
Carteolol—Hypotension—Docetaxel—stomach cancer	0.00027	0.00283	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—stomach cancer	0.000265	0.00278	CcSEcCtD
Carteolol—Dizziness—Fluorouracil—stomach cancer	0.000265	0.00278	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—stomach cancer	0.000264	0.00277	CcSEcCtD
Carteolol—Headache—Irinotecan—stomach cancer	0.000262	0.00275	CcSEcCtD
Carteolol—Hypotension—Capecitabine—stomach cancer	0.000261	0.00274	CcSEcCtD
Carteolol—Insomnia—Docetaxel—stomach cancer	0.000261	0.00274	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—stomach cancer	0.000258	0.00271	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—stomach cancer	0.000258	0.0027	CcSEcCtD
Carteolol—Insomnia—Capecitabine—stomach cancer	0.000253	0.00265	CcSEcCtD
Carteolol—Headache—Fluorouracil—stomach cancer	0.000251	0.00263	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—stomach cancer	0.00025	0.00262	CcSEcCtD
Carteolol—Dyspnoea—Capecitabine—stomach cancer	0.000249	0.00262	CcSEcCtD
Carteolol—Nausea—Irinotecan—stomach cancer	0.000248	0.0026	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—stomach cancer	0.000245	0.00257	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—stomach cancer	0.000245	0.00257	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—stomach cancer	0.00024	0.00252	CcSEcCtD
Carteolol—Nausea—Fluorouracil—stomach cancer	0.000238	0.00249	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—stomach cancer	0.000234	0.00245	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—stomach cancer	0.000227	0.00238	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—stomach cancer	0.000225	0.00236	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—stomach cancer	0.000216	0.00227	CcSEcCtD
Carteolol—Syncope—Epirubicin—stomach cancer	0.000214	0.00225	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—stomach cancer	0.000213	0.00223	CcSEcCtD
Carteolol—Palpitations—Epirubicin—stomach cancer	0.000211	0.00221	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—stomach cancer	0.00021	0.0022	CcSEcCtD
Carteolol—Propranolol—ADRB1—stomach cancer	0.000209	0.0225	CrCbGaD
Carteolol—Vision blurred—Doxorubicin—stomach cancer	0.000208	0.00218	CcSEcCtD
Carteolol—Asthenia—Docetaxel—stomach cancer	0.000207	0.00217	CcSEcCtD
Carteolol—Hypersensitivity—Capecitabine—stomach cancer	0.000206	0.00216	CcSEcCtD
Carteolol—Asthenia—Capecitabine—stomach cancer	0.000201	0.00211	CcSEcCtD
Carteolol—Syncope—Doxorubicin—stomach cancer	0.000198	0.00208	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—stomach cancer	0.000195	0.00205	CcSEcCtD
Carteolol—Oedema—Epirubicin—stomach cancer	0.000195	0.00204	CcSEcCtD
Carteolol—Hypotension—Methotrexate—stomach cancer	0.000195	0.00204	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—stomach cancer	0.000194	0.00204	CcSEcCtD
Carteolol—Shock—Epirubicin—stomach cancer	0.000192	0.00201	CcSEcCtD
Carteolol—Dizziness—Docetaxel—stomach cancer	0.000191	0.002	CcSEcCtD
Carteolol—Insomnia—Methotrexate—stomach cancer	0.000188	0.00198	CcSEcCtD
Carteolol—Propranolol—HTR1A—stomach cancer	0.000187	0.0202	CrCbGaD
Carteolol—Dyspnoea—Methotrexate—stomach cancer	0.000186	0.00195	CcSEcCtD
Carteolol—Dizziness—Capecitabine—stomach cancer	0.000185	0.00194	CcSEcCtD
Carteolol—Hypotension—Epirubicin—stomach cancer	0.000182	0.00191	CcSEcCtD
Carteolol—Headache—Docetaxel—stomach cancer	0.000181	0.0019	CcSEcCtD
Carteolol—Oedema—Doxorubicin—stomach cancer	0.00018	0.00189	CcSEcCtD
Carteolol—Shock—Doxorubicin—stomach cancer	0.000177	0.00186	CcSEcCtD
Carteolol—Insomnia—Epirubicin—stomach cancer	0.000176	0.00185	CcSEcCtD
Carteolol—Propranolol—ADRB2—stomach cancer	0.000176	0.0189	CrCbGaD
Carteolol—Headache—Capecitabine—stomach cancer	0.000175	0.00184	CcSEcCtD
Carteolol—Dyspnoea—Epirubicin—stomach cancer	0.000174	0.00182	CcSEcCtD
Carteolol—Nausea—Docetaxel—stomach cancer	0.000172	0.0018	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—stomach cancer	0.000169	0.00177	CcSEcCtD
Carteolol—Nausea—Capecitabine—stomach cancer	0.000166	0.00174	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—stomach cancer	0.000163	0.00171	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—stomach cancer	0.000161	0.00169	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—stomach cancer	0.000153	0.00161	CcSEcCtD
Carteolol—Asthenia—Methotrexate—stomach cancer	0.000149	0.00157	CcSEcCtD
Carteolol—Hypersensitivity—Epirubicin—stomach cancer	0.000144	0.00151	CcSEcCtD
Carteolol—Asthenia—Epirubicin—stomach cancer	0.00014	0.00147	CcSEcCtD
Carteolol—Dizziness—Methotrexate—stomach cancer	0.000138	0.00144	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—stomach cancer	0.000133	0.00139	CcSEcCtD
Carteolol—Headache—Methotrexate—stomach cancer	0.00013	0.00137	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—stomach cancer	0.000129	0.00136	CcSEcCtD
Carteolol—Dizziness—Epirubicin—stomach cancer	0.000129	0.00135	CcSEcCtD
Carteolol—Nausea—Methotrexate—stomach cancer	0.000124	0.0013	CcSEcCtD
Carteolol—Headache—Epirubicin—stomach cancer	0.000122	0.00128	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—stomach cancer	0.000119	0.00125	CcSEcCtD
Carteolol—Nausea—Epirubicin—stomach cancer	0.000116	0.00121	CcSEcCtD
Carteolol—Headache—Doxorubicin—stomach cancer	0.000113	0.00118	CcSEcCtD
Carteolol—Nausea—Doxorubicin—stomach cancer	0.000107	0.00112	CcSEcCtD
Carteolol—ADRB1—GPCR ligand binding—HTR1A—stomach cancer	4.92e-06	0.00277	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	4.9e-06	0.00275	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HRH4—stomach cancer	4.87e-06	0.00274	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—HTR1A—stomach cancer	4.81e-06	0.00271	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—ANXA1—stomach cancer	4.75e-06	0.00267	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—ANXA1—stomach cancer	4.65e-06	0.00261	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRH4—stomach cancer	4.52e-06	0.00254	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—ADRB1—stomach cancer	4.5e-06	0.00253	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—KISS1—stomach cancer	4.43e-06	0.00249	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRH4—stomach cancer	4.42e-06	0.00248	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—KISS1—stomach cancer	4.34e-06	0.00244	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KISS1—stomach cancer	4.03e-06	0.00226	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KISS1—stomach cancer	3.94e-06	0.00221	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—RGS2—stomach cancer	3.81e-06	0.00214	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GAST—stomach cancer	3.81e-06	0.00214	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—ADRB2—stomach cancer	3.73e-06	0.0021	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GAST—stomach cancer	3.73e-06	0.0021	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—RGS2—stomach cancer	3.73e-06	0.0021	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—GSTP1—stomach cancer	3.72e-06	0.00209	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KISS1R—stomach cancer	3.69e-06	0.00208	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GLI3—stomach cancer	3.69e-06	0.00208	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—GSTP1—stomach cancer	3.67e-06	0.00207	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KISS1R—stomach cancer	3.61e-06	0.00203	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GLI3—stomach cancer	3.61e-06	0.00203	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RBP1—stomach cancer	3.52e-06	0.00198	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—RGS2—stomach cancer	3.46e-06	0.00195	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GAST—stomach cancer	3.46e-06	0.00195	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RBP1—stomach cancer	3.44e-06	0.00194	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—GSTM1—stomach cancer	3.42e-06	0.00192	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GAST—stomach cancer	3.39e-06	0.0019	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—RGS2—stomach cancer	3.39e-06	0.0019	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—GSTM1—stomach cancer	3.37e-06	0.0019	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACAD8—stomach cancer	3.2e-06	0.0018	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AGTR2—stomach cancer	2.89e-06	0.00162	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—WWOX—stomach cancer	2.87e-06	0.00161	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—F2R—stomach cancer	2.86e-06	0.00161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GMPR2—stomach cancer	2.85e-06	0.0016	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	2.83e-06	0.00159	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—WWOX—stomach cancer	2.81e-06	0.00158	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—F2R—stomach cancer	2.79e-06	0.00157	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	2.78e-06	0.00156	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	2.72e-06	0.00153	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	2.69e-06	0.00151	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—WIF1—stomach cancer	2.67e-06	0.0015	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRH4—stomach cancer	2.67e-06	0.0015	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	2.63e-06	0.00148	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	2.62e-06	0.00148	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRH4—stomach cancer	2.61e-06	0.00147	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—WIF1—stomach cancer	2.61e-06	0.00147	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—IDH3B—stomach cancer	2.61e-06	0.00147	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SUCLG1—stomach cancer	2.61e-06	0.00147	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—F2R—stomach cancer	2.59e-06	0.00146	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	2.57e-06	0.00144	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	2.55e-06	0.00143	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	2.54e-06	0.00143	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	2.53e-06	0.00142	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	2.47e-06	0.00139	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	2.46e-06	0.00138	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	2.44e-06	0.00137	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NDUFS1—stomach cancer	2.43e-06	0.00136	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NDUFV1—stomach cancer	2.43e-06	0.00136	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	2.41e-06	0.00135	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	2.39e-06	0.00134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	2.38e-06	0.00134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	2.38e-06	0.00134	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.37e-06	0.00133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	2.33e-06	0.00131	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	2.33e-06	0.00131	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.31e-06	0.0013	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	2.31e-06	0.0013	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PGLS—stomach cancer	2.16e-06	0.00122	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BLVRB—stomach cancer	2.16e-06	0.00122	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FST—stomach cancer	2.12e-06	0.00119	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	2.11e-06	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	2.07e-06	0.00117	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FST—stomach cancer	2.07e-06	0.00117	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPAP2A—stomach cancer	2.06e-06	0.00116	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAST—stomach cancer	2.05e-06	0.00115	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	2.05e-06	0.00115	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	2.03e-06	0.00114	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	2e-06	0.00113	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAST—stomach cancer	2e-06	0.00113	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGG—stomach cancer	1.94e-06	0.00109	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	1.91e-06	0.00108	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGG—stomach cancer	1.9e-06	0.00107	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	1.88e-06	0.00105	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	1.87e-06	0.00105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FBP1—stomach cancer	1.84e-06	0.00103	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NDUFA2—stomach cancer	1.84e-06	0.00103	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CKB—stomach cancer	1.84e-06	0.00103	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CA1—stomach cancer	1.84e-06	0.00103	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	1.83e-06	0.00103	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	1.83e-06	0.00103	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	1.8e-06	0.00101	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	1.8e-06	0.00101	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	1.76e-06	0.000992	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	1.76e-06	0.000991	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLIN2—stomach cancer	1.73e-06	0.000972	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CA2—stomach cancer	1.68e-06	0.000946	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NT5E—stomach cancer	1.64e-06	0.000922	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PGAM1—stomach cancer	1.64e-06	0.000922	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.56e-06	0.000879	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLCE1—stomach cancer	1.56e-06	0.000879	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	1.55e-06	0.000872	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	1.55e-06	0.000872	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	1.53e-06	0.000862	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—F2R—stomach cancer	1.53e-06	0.000862	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	1.52e-06	0.000853	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	1.52e-06	0.000853	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	1.51e-06	0.000848	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	1.5e-06	0.000843	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—F2R—stomach cancer	1.5e-06	0.000843	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UMPS—stomach cancer	1.5e-06	0.000843	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	1.49e-06	0.000839	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	1.48e-06	0.000829	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	1.46e-06	0.000821	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	1.44e-06	0.000812	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	1.44e-06	0.00081	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	1.41e-06	0.000795	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	1.41e-06	0.000793	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PDHA1—stomach cancer	1.39e-06	0.000784	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ECHS1—stomach cancer	1.39e-06	0.000784	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	1.37e-06	0.000768	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	1.33e-06	0.00075	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	1.31e-06	0.000738	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TYMP—stomach cancer	1.31e-06	0.000737	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FADS1—stomach cancer	1.31e-06	0.000737	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.31e-06	0.000735	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.3e-06	0.000733	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.28e-06	0.000722	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.28e-06	0.000719	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SREBF2—stomach cancer	1.23e-06	0.00069	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.23e-06	0.000689	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—RORA—stomach cancer	1.21e-06	0.000682	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.2e-06	0.000674	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.17e-06	0.000656	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.16e-06	0.000652	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.14e-06	0.000641	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDOB—stomach cancer	1.14e-06	0.000639	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.13e-06	0.000638	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.13e-06	0.000636	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.11e-06	0.000623	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.08e-06	0.00061	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALOX5—stomach cancer	1.06e-06	0.000594	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.05e-06	0.000592	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DPYD—stomach cancer	1.04e-06	0.000584	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.03e-06	0.000579	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.03e-06	0.000579	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.02e-06	0.000572	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.01e-06	0.000566	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	9.96e-07	0.00056	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FYN—stomach cancer	9.77e-07	0.000549	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FYN—stomach cancer	9.56e-07	0.000537	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	9.25e-07	0.00052	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTT1—stomach cancer	9.19e-07	0.000517	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	9.17e-07	0.000516	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	9.08e-07	0.000511	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	9.04e-07	0.000509	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	8.97e-07	0.000504	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	8.83e-07	0.000497	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ENO1—stomach cancer	8.61e-07	0.000484	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	8.4e-07	0.000472	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	8.22e-07	0.000462	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	8.14e-07	0.000458	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	8.12e-07	0.000457	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	7.97e-07	0.000448	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	7.95e-07	0.000447	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	7.75e-07	0.000436	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	7.72e-07	0.000434	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD44—stomach cancer	7.64e-07	0.000429	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	7.58e-07	0.000426	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	7.55e-07	0.000425	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APC—stomach cancer	7.42e-07	0.000417	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APC—stomach cancer	7.26e-07	0.000408	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	7.1e-07	0.000399	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	6.95e-07	0.000391	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	6.89e-07	0.000387	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	6.76e-07	0.00038	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	6.76e-07	0.00038	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	6.74e-07	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	6.61e-07	0.000372	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	6.61e-07	0.000372	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	6.49e-07	0.000365	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	6.46e-07	0.000363	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	6.45e-07	0.000363	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	6.38e-07	0.000359	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTP1—stomach cancer	6.37e-07	0.000358	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	6.32e-07	0.000355	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	6.31e-07	0.000355	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—stomach cancer	6.28e-07	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	6.24e-07	0.000351	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	6.22e-07	0.00035	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	6.16e-07	0.000346	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	6.09e-07	0.000342	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	6.02e-07	0.000339	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TYMS—stomach cancer	5.92e-07	0.000333	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	5.86e-07	0.00033	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—stomach cancer	5.85e-07	0.000329	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	5.76e-07	0.000324	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	5.74e-07	0.000323	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	5.63e-07	0.000317	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ERCC2—stomach cancer	5.5e-07	0.000309	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	5.46e-07	0.000307	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	5.43e-07	0.000305	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	5.34e-07	0.0003	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	5.33e-07	0.0003	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	5.31e-07	0.000298	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	5.22e-07	0.000293	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	5.19e-07	0.000292	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—stomach cancer	5.17e-07	0.000291	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	5.09e-07	0.000286	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	5.08e-07	0.000286	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUN—stomach cancer	5.08e-07	0.000285	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	4.98e-07	0.00028	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUN—stomach cancer	4.97e-07	0.000279	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	4.94e-07	0.000278	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	4.92e-07	0.000277	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	4.83e-07	0.000272	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	4.81e-07	0.000271	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	4.8e-07	0.00027	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAV1—stomach cancer	4.77e-07	0.000268	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA1—stomach cancer	4.76e-07	0.000268	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	4.7e-07	0.000264	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	4.44e-07	0.000249	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	4.39e-07	0.000247	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	4.34e-07	0.000244	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	4.3e-07	0.000242	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	4.2e-07	0.000236	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—stomach cancer	4.19e-07	0.000236	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	4.1e-07	0.000231	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—stomach cancer	4.08e-07	0.000229	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	3.99e-07	0.000224	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—stomach cancer	3.99e-07	0.000224	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	3.99e-07	0.000224	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	3.91e-07	0.00022	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	3.9e-07	0.00022	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	3.77e-07	0.000212	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—stomach cancer	3.77e-07	0.000212	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	3.69e-07	0.000207	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—stomach cancer	3.61e-07	0.000203	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	3.46e-07	0.000195	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	3.39e-07	0.000191	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—stomach cancer	3.35e-07	0.000188	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—stomach cancer	3.3e-07	0.000186	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—stomach cancer	3.28e-07	0.000184	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	3.21e-07	0.00018	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	3.14e-07	0.000176	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—stomach cancer	3.07e-07	0.000173	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—stomach cancer	3e-07	0.000169	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.03e-07	0.000114	CbGpPWpGaD
